FDA Releases Draft Guidance on Reducing West Nile Virus Transmission through Nucleic Acid Tests

Summary

The Food and Drug Administration (FDA) has made available a draft document outlining recommendations for using nucleic acid tests to screen donors of whole blood, blood components, and human cells, tissues, and products for West Nile Virus, with the goal of reducing the risk of transmission